Product Information
POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by Strides Pharma Inc., priced at $0.1813 per EA under NDC 42543040701. Its NADAC has been published 457 times since Sep 27, 2017.
Strength
10 meq/1
Manufacturer
Strides Pharma Inc.NDC
42543040701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206813On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 457 times since Sep 27, 2017, and over the history we have for it it has declined 83.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1813 per EA |
|---|---|
| All-time high | $1.0686 (Oct 11, 2017) |
| All-time low | $0.1666 (Sep 17, 2025) |
| 52-week high | $0.2180 |
| 52-week low | $0.1666 |
| Median price | $0.3040 |
| Average price | $0.4319 |
| Largest weekly change | -36.0% (Sep 23, 2020) |
| Weeks tracked | 457 |
| Tracking since | Sep 27, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by Strides Pharma Inc., is $0.1813 per EA (NDC 42543040701), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 83.0%. It has been tracked across 457 weekly CMS publications since Sep 27, 2017.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?
Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $1.0686 (Oct 11, 2017), with a median of $0.3040 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CITRATE ER 10 MEQ TB, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?
POTASSIUM CITRATE ER 10 MEQ TB (NDC 42543040701) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification